FIELD: medicine. SUBSTANCE: this medicine named "Retrovir" is competitive inhibitor of reverse transcriptase. This drug administered in case of viral hepatitis B reduces activity of DNA-polymerase and retards synthesis of DNA minus chain. Consequently, this medicine steps down replicating activity of hepatitis B virus, which is accompanied by rapid disappearance of intoxication syndrome, reduction of icteric period, normalization of biochemical processes, disappearance of superficial antigen, and shortening of hospitalization period. Data obtained point to the fact that disclosed drug produces positive therapeutic effect when administered in dose of 660 mg/day and 750 mg/day to patients suffering from moderately severe form of acute viral hepatitis B. EFFECT: excellent means for treating acute viral hepatitis B. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CHRONIC VIRAL HEPATITIS | 2001 |
|
RU2192881C1 |
METHOD OF TREATMENT OF PATIENTS WITH ACUTE VIRAL HERATITIS B | 1996 |
|
RU2122425C1 |
METHOD OF ACUTE HEPATIC DEFICIENCY DEVELOPMENT PROGNOSIS AT VIRAL HEPATITIS B | 0 |
|
SU1793376A1 |
METHOD FOR TREATING THE CASES OF CHRONIC VIRUS HEPATITIS | 1999 |
|
RU2180235C2 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD OF TREATMENT OF ACUTE VIRAL HEPATITIS B | 2001 |
|
RU2207135C2 |
METHOD FOR INDIVIDUAL MATCHING MEDICINAL PREPARATIONS FOR TREATING PATIENTS WITH ETIOLOGICALLY DIFFERENT ACUTE AND CHRONIC VIRAL HEPATITIS | 2002 |
|
RU2222011C1 |
METHOD FOR TREATING SECONDARY IMMUNODEFICIENCY | 1994 |
|
RU2099051C1 |
METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
METHOD FOR TREATING CHRONIC LIVER DISEASES AGGRAVATED BY HBsAg CARRIAGE WITH LOW INTENSITY HELIUM-NEON LASER IRRADIATION OF BLOOD | 1995 |
|
RU2144836C1 |
Authors
Dates
1995-06-09—Published
1992-06-04—Filed